MiR-486 and miR-92a Identified in Circulating HDL Discriminate between Stable and Vulnerable Coronary Artery Disease Patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
DP Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5
K Ono, 2011, MicroRNAs and cardiovascular diseases, FEBS J, 278, 1619, 10.1111/j.1742-4658.2011.08090.x
EM Kroh, 2010, Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR), Methods, 50, 298, 10.1016/j.ymeth.2010.01.032
KC Vickers, 2011, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nat Cell Biol, 13, 423, 10.1038/ncb2210
A Zampetaki, 2012, Profiling of circulating microRNAs: from single biomarkers to re-wired networks, Cardiovasc Res, 93, 555, 10.1093/cvr/cvr266
J Madrigal-Matute, 2013, MicroRNAs and atherosclerosis, Curr Atheroscler Rep, 15, 322, 10.1007/s11883-013-0322-z
KJ Rayner, 2012, MicroRNAs regulating lipid metabolism in atherogenesis, Thromb Haemost, 107, 642, 10.1160/TH11-10-0694
C Guay, 2013, Circulating microRNAs as novel biomarkers for diabetes mellitus, Nat Rev Endocrinol, 9, 513, 10.1038/nrendo.2013.86
M Jaguszewski, 2014, A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction, Eur Heart J, 35, 999, 10.1093/eurheartj/eht392
EE Creemers, 2012, Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?, Circ Res, 110, 483, 10.1161/CIRCRESAHA.111.247452
VP van Empel, 2012, Circulating miRNAs: reflecting or affecting cardiovascular disease?, Curr Hypertens Rep, 14, 498, 10.1007/s11906-012-0310-7
J Wagner, 2013, Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs, Arterioscler Thromb Vasc Biol, 33, 1392, 10.1161/ATVBAHA.112.300741
D Kaudewitz, 2013, Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease, Thromb Haemost, 110, 609, 10.1160/TH13-05-0368
O Rozenberg, 2005, Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice, Atherosclerosis, 181, 9, 10.1016/j.atherosclerosis.2004.12.030
KE Kypreos, 2005, Generation of a recombinant apolipoprotein E variant with improved biological functions: hydrophobic residues (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) of apoE can account for the apoE-induced hypertriglyceridemia, J Biol Chem, 280, 6276, 10.1074/jbc.M413458200
AV Sima, 2010, Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress, J Cell Mol Med, 14, 2790, 10.1111/j.1582-4934.2009.00933.x
PS Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci USA, 105, 10513, 10.1073/pnas.0804549105
S Fichtlscherer, 2010, Circulating microRNAs in patients with coronary artery disease, Circ Res, 107, 677, 10.1161/CIRCRESAHA.109.215566
A Zampetaki, 2012, Analytical challenges and technical limitations in assessing circulating miRNAs, Thromb Haemost, 108, 592, 10.1160/TH12-02-0097
TD Schmittgen, 2008, Analyzing real-time PCR data by the comparative C(T) method, Nat Protoc, 3, 1101, 10.1038/nprot.2008.73
M Guo, 2010, miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome, Immunol Cell Biol, 88, 555, 10.1038/icb.2010.16
N Simionescu, 2014, Analysis of circulating microRNAs that are specifically increased in hyperlipidemic and/or hyperglycemic sera, Mol Biol Rep, 41, 5765, 10.1007/s11033-014-3449-2
B Meder, 2011, MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction, Basic Res Cardiol, 106, 13, 10.1007/s00395-010-0123-2
CT Lai, 2013, Circulating microRNA expression profile and systemic right ventricular function in adults after atrial switch operation for complete transposition of the great arteries, BMC Cardiovasc Disord, 13, 73, 10.1186/1471-2261-13-73
J Ren, 2013, Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease, PLoS One, 8, e80738, 10.1371/journal.pone.0080738
A Bonauer, 2009, MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice, Science, 324, 1710, 10.1126/science.1174381
X Loyer, 2014, Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice, Circ Res, 114, 434, 10.1161/CIRCRESAHA.114.302213
Y Haraguchi, 2014, Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease, Atherosclerosis, 234, 288, 10.1016/j.atherosclerosis.2014.03.009
J Chang, 2004, miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1, RNA Biol, 1, 106, 10.4161/rna.1.2.1066
W Gao, 2012, Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease, Lipids Health Dis, 11, 55, 10.1186/1476-511X-11-55
MI Oerlemans, 2012, Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs, EMBO Mol Med, 4, 1176, 10.1002/emmm.201201749
K Bidzhekov, 2012, microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans, Thromb Haemost, 107, 619, 10.1160/TH11-09-0607
F Tabet, 2014, HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells, Nat Commun, 5, 3292, 10.1038/ncomms4292
KJ Rayner, 2014, MicroRNA control of high-density lipoprotein metabolism and function, Circ Res, 114, 183, 10.1161/CIRCRESAHA.114.300645